7-Hydroxymethotrexate-d3

CAT:
804-HY-130569S1
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
7-Hydroxymethotrexate-d3 - image 1

7-Hydroxymethotrexate-d3

  • Description :

    7-Hydroxymethotrexate-d3 is the deuterium labeled 7-Hydroxymethotrexate. 7-Hydroxymethotrexate is a major metabolite of Methotrexate (HY-14519) . Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis[1][2].
  • UNSPSC :

    12352005
  • Target :

    Drug Metabolite; Isotope-Labeled Compounds
  • Type :

    Isotope-Labeled Compounds
  • Related Pathways :

    Metabolic Enzyme/Protease; Others
  • Applications :

    Metabolism-protein/nucleotide metabolism
  • Field of Research :

    Metabolic Disease
  • Solubility :

    10 mM in DMSO
  • Smiles :

    O=C(O)CC[C@@H](C(O)=O)NC(C1=CC=C(N(CC2=NC3=C(N)N=C(N)N=C3NC2=O)C([2H])([2H])[2H])C=C1)=O
  • Molecular Formula :

    C20H19D3N8O6
  • Molecular Weight :

    473.46
  • References & Citations :

    [1]L Fahrig, et al. Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX. Cancer Chemother Pharmacol. 1989;23 (3) :156-60. |[2]Ping Guo, et al. Determination of methotrexate and its major metabolite 7-hydroxymethotrexate in mouse plasma and brain tissue by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2007 Apr 11;43 (5) :1789-95. |[3]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-223.
  • Shipping Conditions :

    Room temperature
  • Scientific Category :

    Isotope-Labeled Compounds
  • Clinical Information :

    No Development Reported
  • CAS Number :

    [432545-62-5]